triazolam has been researched along with fluoxetine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lasher-Sisson, TA; Steenwyk, RC; Swanson, CN; Wright, CE | 1 |
| Leonsegui, I; Salvador-Carulla, L | 1 |
| Antelman, SM; Gershon, S | 1 |
| Arai, Y; Hishinuma, T; Hozumi, M; Kinemuchi, H; Kisara, K; Mizugaki, M; Nakagawasai, O; Niijima, F; Oka, R; Satoh, N; Tadano, T; Tan-no, K; Yasuhara, H | 1 |
3 review(s) available for triazolam and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Psychosocial effects in pharmacology: something more than an anecdote?].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Clozapine; Fluoxetine; Humans; Hypnotics and Sedatives; Psychology, Social; Psychopharmacology; Triazolam | 1995 |
Clinical application of time-dependent sensitization to antidepressant therapy.
Topics: Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Administration Schedule; Electroconvulsive Therapy; Fluoxetine; Humans; Time Factors; Triazolam | 1998 |
7 other study(ies) available for triazolam and fluoxetine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine.
Topics: Adult; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Fluoxetine; Humans; Middle Aged; Tablets; Triazolam | 1992 |
Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Behavior, Animal; Dihydroxytryptamines; Estazolam; Fluoxetine; GABA-A Receptor Agonists; Hypnotics and Sedatives; Ketanserin; Male; Mice; Piperazines; Receptors, GABA-A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Triazolam | 2001 |